Does the pharmacist’s duty of care extend to warning patients about the possible adverse effects of nonprescription drugs?
Pharmacists are responding to threats of violence in a variety of ways, including arming themselves as a means of self-defense.
As this case demonstrates, pharmacists should never access patient information for personal reasons.
Do patients have a reasonable expectation of privacy with regard to their prescription drug information?
The New England Compounding Center meningitis outbreak inspired the creation of the Drug Quality and Security Act.
The time between an injury caused by a pharmaceutical mistake and the filing of a lawsuit is often crucial.
Recent shortages of drugs used for the death penalty further complicate this controversial issue.
Can you be convicted of a DUI if taking a prescription drug as directed?
Two recent cases in Michigan involve pharmacists charged with running illegal prescription drug schemes.
Three cases involving at-will employment of pharmacists examine whether their terminations were legal.
The largest insider-trading case in history involves a
doctor who provided results from an Alzheimer’s drug trial to a hedge
Does the ban on off-label marketing of drugs violate a pharmaceutical sales representative’s freedom of speech?
The company at the center of the fungal meningitis
outbreak was acting as a manufacturer and not as a traditional
Illinois pharmacists are no longer required to dispense
emergency contraception when their own religious beliefs are opposed to
E-prescribing of controlled substances and prescription misuse are among the many issues being addressed by the DEA.
Demands for pharmacist services under the ACA are likely to have a huge impact on future workforce needs.
As gatekeepers of controlled substances, pharmacists must distinguish between legitimate and questionable prescriptions.
According to a government report, questionable Medicare Part D billing seems to be on the rise in community pharmacies.
Another chain-store pharmacy is being investigated for distributing “too much” oxycodone.
The DEA’s expectations for policing pharmacies and their patients who request controlled substances are unclear.
For more articles, please check our archives.